Group One Trading’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-34,035
Closed -$603K – 8343
2026
Q2
$546K Buy
+34,035
New +$563K ﹤0.01% 3414
2025
Q3
– Sell
-147
Closed -$2.18K – 9127
2025
Q2
$2.27K Sell
147
-100
-40% -$1.48K ﹤0.01% 7381
2025
Q1
$3.67K Sell
247
-28
-10% -$392 ﹤0.01% 6773
2024
Q4
$3.64K Sell
275
-7,607
-97% -$104K ﹤0.01% 6548
2024
Q3
$112K Buy
+7,882
New +$112K ﹤0.01% 4083
2023
Q3
– Sell
-4,975
Closed -$77K – 8288
2023
Q2
$78.2K Sell
4,975
-10,963
-69% -$180K ﹤0.01% 4864
2023
Q1
$263K Buy
+15,938
New +$254K ﹤0.01% 3413
2022
Q4
– Sell
-18,386
Closed -$257K – 8066
2022
Q3
$238K Sell
18,386
-35,346
-66% -$491K ﹤0.01% 3966
2022
Q2
$754K Buy
53,732
+31,403
+141% +$448K ﹤0.01% 3020
2022
Q1
$320K Buy
+22,329
New +$328K ﹤0.01% 4304
2021
Q1
– Sell
-39,227
Closed -$706K – 8012
2020
Q4
$714K Buy
+39,227
New +$688K ﹤0.01% 2949
2019
Q2
– Sell
-19,202
Closed -$349K – 5376
2019
Q1
$391K Buy
+19,202
New +$386K ﹤0.01% 2152

Other funds holding TAK

Group One Trading's TAK Position: Q3 2026 in Review

Group One Trading sold out of Takeda Pharmaceutical (TAK) in Q3 2026, closing a stake of 34,035 shares — an estimated $603K sold.

Group One Trading first reported a position in TAK in Q1 2019 and held it in 12 quarters. The position peaked at $754K in Q2 2022. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Group One Trading reported no remaining Takeda Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 34,035 Takeda Pharmaceutical shares in Q3 2026, an estimated $603K.
  • Group One Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 12 quarters.
  • Group One Trading's Takeda Pharmaceutical position peaked at $754K in Q2 2022.
  • 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.